Combining two repurposed drugs as a promising approach for Alzheimer's disease therapy Article Swipe

PDF

Ilya Chumakov , Serguei Nabirotchkin , Nathalie Cholet , Aude Milet , Aurélie Boucard , Damien Toulorge , Yannick Pereira , Esther Graudens , S Traoré , Julie Foucquier , Mickaël Guedj , Emmanuel Vial , Noëlle Callizot , Rémy Steinschneider , Tangui Maurice , Viviane Bertrand , Catherine Scart‐Grès , Rodolphe Hajj , Daniel Cohen ·

YOU? · · 2015 · Open Access · · DOI: https://doi.org/10.1038/srep07608

Related Topics To Compare & Contrast

List Of Designer Drugs

The War On Drugs (Band)

Effect Of Psychoactive Drugs On Animals

How To Sell Drugs Online (Fast)

Misuse Of Drugs Act (Singapore)

United Nations Office On Drugs And Crime

Love & Other Drugs

Wrld On Drugs

Sex, Drugs, And Cocoa Puffs

Controlled Drugs And Substances Act

Concepts

Neuroprotection Glutamatergic Pharmacology Neuroscience Genetically modified mouse In vivo Glutamate receptor Inhibitory postsynaptic potential Medicine Combination therapy Biology Transgene Receptor Biochemistry Internal medicine Biotechnology Gene

Metadata

Type: article
Language: en
Landing Page: https://doi.org/10.1038/srep07608
PDF: https://www.nature.com/articles/srep07608.pdf
OA Status: gold
Cited By: 64
References: 74
Related Works: 10
OpenAlex ID: https://openalex.org/W2083505459

All OpenAlex metadata

Raw OpenAlex JSON

No additional metadata available.